Sector portfolio · VC firm · United States
Versant Ventures' Healthtech portfolio
Versant Ventures has backed 10 Healthtech startups in rounds we track, $343M between them, shown by the stage each has reached. The best-funded is Enterprise Therapeutics.
Versant Ventures's whole portfolioVersant Ventures's profile
Funding by segment
- Series C and later$112M4
- Stage not reported$128M4
- Series B$103M2
Where they are based
- United States9$262M
- United Kingdom1$80M
United States
United KingdomFounded
Total raised
- Under $1M0
- $1M to $10M0
- $10M to $50M8
- $50M to $250M2
- $250M to $1B0
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
10 of 10 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States9
- United Kingdom1
Startups by country, 2 countries in all.
Segment by segment
Series C and later
4 startups · $112M raised
- NSNeoGuide SystemsNeoGuide Systems develops robotic endoscopic technology for natural orifice transluminal endoscopic surgery.United States$39M
AugmenixSpaceOAR designs, develops and commercializes hydrogel based medical devices for radiation oncology, urology and cancer surgery.United States$36M
ConcuityConcuity provides revenue cycle management software and services for contract profitability and compliance, denial management, and more.United States$19M- AIAdvanced ICU CareHicuity Health, formerly known as Advanced ICU Care, is a leading provider of high-acuity telehealth services in the United States.United States$18M
Stage not reported
4 startups · $128M raised
GluMetricsGluMetrics, a medical company based in Irvine, California, develops tools that enable clinicians to implement a care paradigm for patients.United States$51M
LENZ TherapeuticsLENZ Therapeutics operates as an organization engaged in the late-stage clinical development of pharmaceuticals for the eyes.United States$30M
VenatoRx PharmaceuticalsVenatorx Pharmaceuticals develops anti-infectives to treat multi-drug-resistant bacterial infections and viral infections.United States$28M
ForSight VISION5ForSight VISION5 was founded in 2010 as the fifth company created by the ophthalmic product incubator, ForSight Labs.United States$20M
Series B
2 startups · $103M raised
Enterprise TherapeuticsEnterprise Therapeutics Ltd is a UK-based biopharmaceutical company founded in 2014, located at the Sussex Innovation Centre in Brighton.United Kingdom$80M
LensX LasersLensX Lasers is a developer of surgical lasers used for the reparation of cataracts.United States$22M
How this map is made. Every startup here works in Healthtech and has raised money in a round we track that names Versant Ventures as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Versant Ventures?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.